SCHOTT Pharma Announces Innovative Cartridge Nesting for Efficiency and Sustainability

Source: SCHOTT Pharma

SCHOTT Pharma, the pharma drug containment solutions and delivery systems company, has unveiled a groundbreaking nest design for ready-to-use cartridges to improve operational efficiency and sustainability for pharmaceutical manufacturing. The new design optimizes the arrangement of cartridges, reducing the risk of breakage and contamination during high-speed automated filling, and enhancing productivity by streamlining the fill-and-finish process, resulting in faster handling and increased throughput.

The nest design also promotes sustainability by reducing packaging materials and lowering the overall carbon footprint, helping pharmaceutical companies meet the rising demand for injectable drugs without compromising quality or compliance in line with regulatory standards.

SCHOTT Pharma, a pioneer in drug containment and delivery solutions, announces the launch of its groundbreaking nest design for ready-to-use (RTU) cartridges known as cartriQ®. The new nest retains its external dimensions, while the cartridges are fixated in diamond-shaped holes instead of round ones. This optimized configuration significantly increases the packing density by up to 60% while improving stability, which is crucial as the cartridges remain in the nest during the entire filling process. “With this revolutionary product, we are proactively addressing one of the key factors in reducing costs for pharmaceutical companies and reorganizing their value chain. Our new nest for RTU cartridges not only enhances operational efficiency by up to 67% when using 1.5 ml cartridges, but also significantly contributes to sustainability efforts in the industry," said Andreas Reisse, CEO of SCHOTT Pharma. "We have received positive feedback from our customers so far," he adds, citing the case of a Big Pharma company where the new nest for 3 ml RTU cartridges has also been optimized for high packaging density using the same approach. In the long term, this change can save a pharma company a considerable amount of CO2 per year.

SCHOTT Pharma’s new nest is available For Human Use (FHU) and is manufactured at the company’s production site in St. Gallen, Switzerland with the outlook of further sites adopting it in the future. It is a complete solution that enhances the efficient filling of high-quality drugs, such as GLP-1, insulin, and hormone therapies. Depending on the requirements of the drug and therefore the format of the cartridge, SCHOTT Pharma managed to fit as many as 160 RTU cartridges in one nest when using the 1.5 ml cartriQ® format while ensuring highest quality and stability.

For more, please find the original story source here.